NEW YORK (GenomeWeb News) — DeCode Genetics today said third-quarter revenues decreased 35 percent as R&D spending rose 29 percent and loss increased 108 percent.
 
Total receipts for the three months ended Sept. 30 decreased to $8.6 million from $13.2 million year over year. Decode blamed the decline on lower alliance revenues in 2006, and because $11.8 million in revenue was deferred to future reporting periods.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Vivek Murthy is no longer the surgeon general of the US, the Associated Press reports.

People around the globe took to the streets to support science — some with signs.

Parents who learn of their increased genetic risk of disease also contend with telling their children about theirs, the New York Times writes.

In PLOS this week: loci linked to body mass index measurements, long non-coding RNA expression and urothelial carcinoma prognosis, and more.